Literature DB >> 11494224

Riboflavin carrier protein: a serum and tissue marker for breast carcinoma.

A A Karande1, L Sridhar, K S Gopinath, P R Adiga.   

Abstract

We have earlier shown that the estrogen-modulated riboflavin carrier protein (RCP) first isolated from the chicken egg is evolutionarily conserved in mammals and is elaborated by lactating mammary gland as demonstrated with rat mammary epithelial cells in culture and confirmed by isolation of the vitamin carrier from bovine milk. In view of several earlier reports that many milk proteins as well as other estrogen-inducible proteins are up-regulated and secreted into circulation in animal models and in women with neoplastic breast disease, we analyzed serum RCP levels in a double-blind study using a specific radioimmunoassay in pre- and post-menopausal women with clinically diagnosed breast cancer at early and advanced stages of the disease and compared these levels with those in normal age-matched control volunteers. Our data reveal that the serum RCP levels in cycling breast cancer patients are 3- to 4-fold higher (p < 0.01) than those in their normal counterparts. This difference in circulatory RCP levels between cancer patients and their age-matched normal counterparts is further magnified to 9- to 11-fold (p < 0.005) at the post-menopausal stage. In addition, there seems to be a good correlation between rising RCP levels and disease progression, since significantly higher RCP concentrations (p < 0.005) are encountered in patients with advanced metastasizing breast cancer versus those with early disease. Using specific monoclonal antibodies, RCP could be localized immunohistochemically in the cytoplasm of invading neoplastic cells of lobular and ductal carcinomas of the breast, indicating that the malignant cells are probably the source of the elevated serum RCP levels in breast cancer. These findings suggest that measurement of circulatory RCP and the immunohistochemical staining pattern of RCP in biopsy specimens could be exploited as an additional marker in diagnosis/prognosis of breast cancer in women. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494224     DOI: 10.1002/1097-0215(20010920)95:5<277::aid-ijc1047>3.0.co;2-y

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Bioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery - A Thermodynamic and Kinetic Study.

Authors:  Anna Plantinga; Amanda Witte; Ming-Hsin Li; Andrew Harmon; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  ACS Med Chem Lett       Date:  2011-05-12       Impact factor: 4.345

2.  Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.

Authors:  Amanda B Witte; Christine M Timmer; Jeremy J Gam; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  Biomacromolecules       Date:  2012-01-18       Impact factor: 6.988

3.  Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery.

Authors:  Thommey P Thomas; Seok Ki Choi; Ming-Hsin Li; Alina Kotlyar; James R Baker
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

4.  Riboflavin-targeted polymer conjugates for breast tumor delivery.

Authors:  Lisa M Bareford; Brittany R Avaritt; Hamidreza Ghandehari; Anjan Nan; Peter W Swaan
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

Review 5.  Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.

Authors:  Micah D K Glasgow; Mahavir B Chougule
Journal:  J Biomed Nanotechnol       Date:  2015-11       Impact factor: 4.099

6.  Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy.

Authors:  Mi Kyung Yu; Jinho Park; Sangyong Jon
Journal:  Theranostics       Date:  2012-01-01       Impact factor: 11.556

7.  Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers.

Authors:  Nataliia Beztsinna; Yoanna Tsvetkova; Jithin Jose; Boutayna Rhourri-Frih; Wa'el Al Rawashdeh; Twan Lammers; Fabian Kiessling; Isabelle Bestel
Journal:  Int J Nanomedicine       Date:  2017-05-18

8.  Topological, chemical and electro-optical characteristics of riboflavin-doped artificial and natural DNA thin films.

Authors:  Bramaramba Gnapareddy; Sreekantha Reddy Dugasani; Junyoung Son; Sung Ha Park
Journal:  R Soc Open Sci       Date:  2018-02-14       Impact factor: 2.963

9.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07

10.  Atomic force microscopy probing of receptor-nanoparticle interactions for riboflavin receptor targeted gold-dendrimer nanocomposites.

Authors:  Amanda B Witte; Abigail N Leistra; Pamela T Wong; Sophia Bharathi; Kevin Refior; Phillip Smith; Ola Kaso; Kumar Sinniah; Seok Ki Choi
Journal:  J Phys Chem B       Date:  2014-03-07       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.